SCHEMBL8080123

SCHEMBL8080123

C[Si](C)(C)n1ccc(N)nc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
THRB P10828 1/20 0.39
MTOR P42345 1/20 0.39
MDM2 Q00987 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
PDE3A Q14432 3/20 0.37
CACNA1F O60840 2/20 0.37
ALB P02768 2/20 0.37
MAPT P10636 2/20 0.37
CACNA1D Q01668 2/20 0.37
CACNA1S Q13698 2/20 0.37
CACNA1C Q13936 2/20 0.37
PDE4D Q08499 1/20 0.36
SLC29A1 Q99808 1/20 0.36
FGFR1 P11362 3/20 0.35
SLC22A6 Q4U2R8 1/20 0.33
NT5E P21589 1/20 0.32
NOS3 P29474 2/20 0.31
NOS2 P35228 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27952255 0.74 PIK3CB (0.41) LMNATHRBMTORMDM2NCOA1
SCHEMBL19929 0.74
SCHEMBL1065338 0.73 FGFR1 (0.35) LMNATHRBMTORMDM2NCOA1
Iodide SCHEMBL29172953 0.72 PIK3CB (0.40) LMNATHRBMTORMDM2NCOA1
Hydrochloric Acid SCHEMBL6853659 0.72 PIK3CB (0.40) LMNATHRBMTORMDM2NCOA1
SCHEMBL22782146 0.72 LMNA (0.36) LMNATHRBMTORMDM2NCOA1
SCHEMBL25378286 0.71
SCHEMBL22016090 0.71
SCHEMBL11894064 0.71
SCHEMBL26050223 0.71 LMNA (0.33) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380877-A Preparation method of 2' -deoxy-2 ' -beta-fluoro-4 ' -azidocytidine 和德化学(苏州)有限公司 2022-04-22 CN claimed
CN-112979723-B Gemcitabine intermediate purification method 江苏科本药业有限公司 2022-09-02 CN disclosed
CN-112979724-B Mother liquor recovery method of gemcitabine intermediate 浙江外国语学院 2022-04-22 CN disclosed
CN-114380877-A Preparation method of 2' -deoxy-2 ' -beta-fluoro-4 ' -azidocytidine 和德化学(苏州)有限公司 2022-04-22 CN disclosed
CN-112979724-A Mother liquor recovery method of gemcitabine intermediate 浙江外国语学院 2021-06-18 CN disclosed
CN-112979723-A Gemcitabine intermediate purification method 江苏科本药业有限公司 2021-06-18 CN disclosed
CN-110483413-A The method for being used to prepare carbocyclic ring sugar derivatives REXAHN PHARMACEUTICALS INC 2019-11-22 CN disclosed
CN-107474034-A Method for preparing carbocyclic ring sugar derivatives 瑞沙恩医药公司 2017-12-15 CN disclosed
CN-105143191-B Process for the preparation of 4-amino-1- ((1S, 4R, 5S) -2-fluoro-4, 5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl) -1H-pyrimidin-2-one 瑞沙恩医药公司 2017-08-25 CN disclosed
CN-105143191-A Process for the preparation of 4-amino-1- ((1S, 4R, 5S) -2-fluoro-4, 5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl) -1H-pyrimidin-2-one REXAHN PHARMACEUTICALS INC 2015-12-09 CN disclosed
WO-2014160799-A1 AN AUTOMATED, MULTI-POT HIGH-PRESSURE RADIO-SYNTHESIZER FOR PRODUCTION OF PET TRACERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-02 WO disclosed
US-6034087-A VIRICIDE AGAINST HEPATITIS B CHONG KUN DANG CORP. (KR) 2000-03-07 US disclosed
EP-0350293-A2 Process for preparing derivatives of 2'-deoxy-beta-cytidine and salts thereof Japan Tobacco Inc. (JP) 1990-01-10 EP disclosed